Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Amber Implants B.V.

Clinicaltrial registered5 Nov 2026

Amber Implants B.V.

5 Nov 2026: Trial registered · A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
5 Nov 2026
Title
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Conditions
Vertebra Compression Fracture
Study Type
Observational
Status
Recruiting
Countries
United States
Country
United States
Reference
NCT07920484
Location
United States
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Amber Implants B.V.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.